{"version":"1.0","provider_name":"Vidal-Quadras&amp;Ramon","provider_url":"https:\/\/vidalquadrasramon.com\/en\/","author_name":"Sonia Sarroca Su\u00f1er","author_url":"https:\/\/vidalquadrasramon.com\/en\/author\/sonia-sarroca\/","title":"Sorafenib: a divergent case, like so many others - Vidal-Quadras&amp;Ramon","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"uwYGFOZF66\"><a href=\"https:\/\/vidalquadrasramon.com\/en\/sorafenib-a-divergent-case-like-so-many-others\/\">Sorafenib: a divergent case, like so many others<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/vidalquadrasramon.com\/en\/sorafenib-a-divergent-case-like-so-many-others\/embed\/#?secret=uwYGFOZF66\" width=\"600\" height=\"338\" title=\"&#8220;Sorafenib: a divergent case, like so many others&#8221; &#8212; Vidal-Quadras&amp;Ramon\" data-secret=\"uwYGFOZF66\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/vidalquadrasramon.com\/wp-includes\/js\/wp-embed.min.js\n<\/script>\n","thumbnail_url":"https:\/\/vidalquadrasramon.com\/wp-content\/uploads\/2025\/01\/img-patentes-vqr25.jpg","thumbnail_width":1200,"thumbnail_height":831,"description":"By Judgment of 30 September 2024, the Commercial Court No. 1 of Barcelona dismissed the infringement action brought by three companies of the BAYER Group against four companies that had launched generic drugs based on the active ingredient sorafenib in the form of its tosylate salt on the Spanish market. The Court, upholding the defendants&#8217; ... Read more"}